Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-10

Clinical Trial Update: Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients

View source ↗

Summary

The study reported a completed trial evaluating whether better glucose control in type 2 diabetes affects the response to aspirin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Diabetes Mellitus, Type II | Status: COMPLETED